$ASTSBullishMed

AST SpaceMobile (NASDAQ: ASTS) Plans June 17 BlueBird Satellite Launch To Reverse Four-Session Slump

AST SpaceMobile (NASDAQ: ASTS) said it will launch BlueBird 8, 9 and 10 on a SpaceX Falcon 9 from Cape Canaveral on June 17, aiming to deliver space-based cellular broadband to unmodified smartphones. The plan follows BlueBird 7’s April failure, which the CEO said was due to the rocket’s second stage. Barclays cut its price target to $60 from $65 (Underweight).

8/10
8/10
Med
Bullish
Pre-market today; catalyst is the June 17 BlueBird 8/9/10 launch confirmation.
Improves risk appetite for ASTS via a dated execution milestone, partially offset by Barclays’ PT cut and Underweight stance.

Near-term sentiment likely improves on a concrete next launch date, but investors may still discount execution risk given the prior failed orbit attempt.

AST SpaceMobile confirmed a June 17 launch of BlueBird 8/9/10 on a SpaceX Falcon 9 after BlueBird 7’s April orbit failure.

Bias toward continued pre-launch strength/volatility; upside may fade if launch readiness or performance concerns resurface.

Background

BlueBird 7 failed to reach intended orbit in April on Blue Origin’s New Glenn Mission-3, though it separated and powered on.

Why it matters

A confirmed June 17 Falcon 9 launch date for BlueBird 8/9/10 is a tangible de-risking step for the program, but the prior orbit miss and analyst caution keep the risk premium elevated.

Market relevance

Traders can frame ASTS around a near-term, dated mission catalyst while monitoring whether the market treats it as meaningful de-risking versus another execution-risk event.

Market effects

Reinforces investor focus on space-based cellular broadband execution and launch reliability as a key differentiator for satellite connectivity players.

Limited; primary impact is on US-listed satellite/space names tied to launch schedules.

Moderate via the company’s stated global operator partnerships supporting the business case for direct-to-unmodified smartphones.

Alternative perspectives

The stock’s bounce may be largely “schedule relief” rather than proof of end-to-end mission success, especially after BlueBird 7’s second-stage orbit failure.

Execution risk remains high (rocket stage performance, integration, and in-orbit commissioning); the Barclays Underweight/PT cut suggests the market may demand evidence beyond a planned launch date.

Key entities

  • AST SpaceMobile

    Plans June 17 launch of BlueBird 8/9/10 satellites to support direct-to-smartphone space-based cellular broadband.

  • SpaceX

    Falcon 9 rocket provider for the June 17 BlueBird 8/9/10 launch.

  • Barclays

    Cut ASTS price target to $60 from $65 and kept an Underweight rating citing launch delays and operating performance.

Related articles

$ASTSMedAI 8/10

Why Shares of AST SpaceMobile Collapsed 25% This Week

AST SpaceMobile (ASTS) shares fell about 25% this week, after the company finalized a $1 billion convertible note raise on July 15, according to S&P Global Market Intelligence. The notes carry 1.6% annual interest, convert above a $79.60 price, and expire in 2034. ASTS trades near $55 and is down 59% from recent highs.

$ASTSMedAI 8/10

AST SpaceMobile: Shares Sink 17% After Pricing a $1 Billion Convertible-Note Offering, But Dilution Risk Is Smaller Than It Looks (NASDAQ:ASTS)

AST SpaceMobile (ASTS) shares fell about 17% after the company priced a $1 billion convertible senior note offering. The notes carry a 1.625% coupon, mature Feb. 2034, and have a $79.57 conversion price. AST expects about $983.6 million net proceeds, plus an option for $150 million more, and targets ~45 BlueBird satellites in early 2027.

$ASTSMedAI 8/10

Why AST SpaceMobile Stock Just Crashed

AST SpaceMobile said it will raise $1 billion via a private offering of convertible senior notes, with an initial conversion price just under $80 per share, according to the company. ASTS shares fell about 15.5% to around $53.40 by 11:07 a.m. ET. The article also cites dilution concerns and competition from SpaceX’s Starlink.